CLINICAL RESEARCH FOR ALOPECIA AREATA: INJECTABLE

Alopecia Areata is estimated to affect 6.8 million Americans and can affect both men and women of all races. Common signs of Alopecia Areata are smooth coin like patches along the scalp.

We are currently conducting a clinical research study testing an injectable investigational medication on patients with Alopecia Areata. We are looking for participants who meet the following criteria:

• Male or Female
• 18-75 years old
• 50% or more hair loss
• 6 Months - 1 year clinical diagnosis of AA

*Other qualifications will be checked during a screening visit with a board-certified provider. * 

*Even if you do not qualify you will receive a consultation & recommendations for treatment at no cost by a board-certified provider.*  

Study Duration: Approximately 9 months